FACTOR-XIII(A CALGARY) - A CANDIDATE MISSENSE MUTATION (LEU667PRO) IN THE BETA-BARREL 2 DOMAIN OF THE FACTOR-XIII(A) SUBUNIT

被引:29
作者
ASLAM, S
POON, MC
YEE, VC
BOWEN, DJ
STANDEN, GR
机构
[1] UNIV BRISTOL, BRISTOL ROYAL INFIRM, DEPT HAEMATOL, MOLEC HAEMATOL UNIT, BRISTOL BS2 8HW, AVON, ENGLAND
[2] UNIV CALGARY, FOOTHILLS HOSP, DEPT MED, CALGARY, AB, CANADA
[3] UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA
[4] UNIV WASHINGTON, DEPT BIOL STRUCT, SEATTLE, WA 98195 USA
[5] UNIV WALES COLL CARDIFF, COLL MED, DEPT HAEMATOL, CARDIFF, S GLAM, WALES
关键词
FACTOR XIII; A SUBUNIT; GENE; HOMOZYGOUS; MUTATION;
D O I
10.1111/j.1365-2141.1995.tb05321.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Molecular analysis performed on a Canadian family with congenital factor XIII deficiency revealed a homozygous missense mutation (Leu667Pro) in exon 14 of the A subunit gene in three affected siblings. The mutation results from a T-to-C transition at nucleotide position 2087 and generates a new Mspl restriction site. Digestion of an amplified fragment containing exon 14 with this restriction enzyme enabled the heterozygous allele to be identified in both parents (who were third cousins) and three other family members. SSCP analysis detected no additional mutations in the coding or consensus splice sequences of the A subunit gene. The mutant nucleotide substitution was absent in 60 normal alleles and 10 unrelated patients with XIII(A) deficiency. Leu667 is located in the carboxyl terminal beta barrel 2 domain of the A subunit molecule. Computer modelling based on 3D crystallographic data predicts that the mutant protein has aberrant folding and is likely to be rapidly degraded following translation.
引用
收藏
页码:452 / 457
页数:6
相关论文
共 25 条
  • [1] BOARD P, 1992, BLOOD, V80, P937
  • [2] FACTOR-XIII - INHERITED AND ACQUIRED DEFICIENCY
    BOARD, PG
    LOSOWSKY, MS
    MILOSZEWSKI, KJA
    [J]. BLOOD REVIEWS, 1993, 7 (04) : 229 - 242
  • [3] CRYSTALLOGRAPHIC R-FACTOR REFINEMENT BY MOLECULAR-DYNAMICS
    BRUNGER, AT
    KURIYAN, J
    KARPLUS, M
    [J]. SCIENCE, 1987, 235 (4787) : 458 - 460
  • [4] CALCIUM-DEPENDENT UNMASKING OF ACTIVE-CENTER CYSTEINE DURING ACTIVATION OF FIBRIN STABILIZING FACTOR
    CURTIS, CG
    BROWN, KL
    CREDO, RB
    DOMANIK, RA
    GRAY, A
    STENBERG, P
    LORAND, L
    [J]. BIOCHEMISTRY, 1974, 13 (18) : 3774 - 3780
  • [5] Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X
  • [6] CHARACTERIZATION OF CDNA CODING FOR HUMAN FACTOR-XIIIA
    GRUNDMANN, U
    AMANN, E
    ZETTLMEISSL, G
    KUPPER, HA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) : 8024 - 8028
  • [7] 2 GENETIC-DEFECTS IN A PATIENT WITH COMPLETE DEFICIENCY OF THE B-SUBUNIT FOR COAGULATION FACTOR-XIII
    HASHIGUCHI, T
    SAITO, M
    MORISHITA, E
    MATSUDA, T
    ICHINOSE, A
    [J]. BLOOD, 1993, 82 (01) : 145 - 150
  • [9] IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS
    JONES, TA
    ZOU, JY
    COWAN, SW
    KJELDGAARD, M
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 : 110 - 119
  • [10] DEFICIENCY OF COAGULATION FACTOR-XIII A SUBUNIT CAUSED BY THE DINUCLEOTIDE DELETION AT THE 5' END OF EXON-III
    KAMURA, T
    OKAMURA, T
    MURAKAWA, M
    TSUDA, H
    TESHIMA, T
    SHIBUYA, T
    HARADA, M
    NIHO, Y
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) : 315 - 319